{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:48:03Z","timestamp":1776426483528,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cystic fibrosis (CF) is one of the most frequent genetic diseases and the median survival of these patients has improved in the last few decades, therefore it becomes necessary to evaluate the long-term complications as renal and cardiovascular risk factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim of the study<\/jats:title>\n                <jats:p>To evaluate the incidence, the manifestations of renal disease and the possible association with metabolic and endothelial dysfunction markers in the CF population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>We performed a cross-sectional, observational study on 226 CF patients. Clinical and laboratory instrumental parameters (metabolic, inflammatory and endothelial dysfunction markers) were evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We showed 65 patients with chronic kidney disease (CKD) and 158 patients with a reduced value of forced expiratory volume in 1\u00a0s (FEV1), of which 58 patients with a severe reduction of FEV1. Moreover 28 patients had undergone lung transplantation and them had a significant lower estimated Glomerular Filtration Rate (eGFR) with respect to the non-transplanted patients (p\u2009&lt;\u20090.001). We reported also a significant association between lower eGFR value and serum triglycerides, total cholesterol and low-density lipoproteins (LDL) (p\u2009=\u20090.005, p\u2009&lt;\u20090.001, p\u2009=\u20090.040; respectively), with a significant negative correlation between eGFR and serum triglycerides (r\u2009=\u2009\u2212\u20090.28; p\u2009&lt;\u20090.01). Moreover we found a significant association between lower eGFR value and serum uric acid (SUA) (p\u2009=\u20090.005), while we did not found an association with 25-hydroxy-vitamin-D value, serum glucose and hemoglobin A1c levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study showed a high prevalence of CKD in CF patients. Moreover we showed an increase of endothelial dysfunction and metabolic indexes in patients with reduced renal function, as SUA, serum triglycerides and LDL, suggesting the need for an early and complete screening of the main metabolic indexes to reduce cardiovascular risk and progression of renal damage, in particular in patients with lung transplant.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-019-02139-4","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T19:02:48Z","timestamp":1574708568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Silvia","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Paola","family":"Mitterhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enea","family":"Bonci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Giangreco","family":"Marotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pelligra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Murciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Celani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Troiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Palange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"key":"2139_CR1","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"J Elborn","year":"2016","unstructured":"Elborn J. Cystic fibrosis. Lancet. 2016;388:2519\u201331.","journal-title":"Lancet"},{"key":"2139_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jcf.2017.11.013","volume":"17","author":"Abaigeal D Jackson","year":"2018","unstructured":"Jackson Abaigeal D, Goss Christopher H. Epidemiology of CF: how registries can be used to advance our understanding of the CF population. J Cyst Fibros. 2018;17:297\u2013305.","journal-title":"J Cyst Fibros"},{"key":"2139_CR3","first-page":"129","volume":"74","author":"Carlo Castellani","year":"2016","unstructured":"Castellani Carlo, Assael Baroukh M. Cystic Fibrosis: a clinical view. Springer Int. 2016;74:129\u201340.","journal-title":"Springer Int"},{"key":"2139_CR4","first-page":"1251","volume":"73","author":"Michael J Welsh","year":"1993","unstructured":"Welsh Michael J, Smith Alan E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell Press. 1993;73:1251\u20134.","journal-title":"Cell Press"},{"key":"2139_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","volume":"154","author":"Martina Gentzsch","year":"2018","unstructured":"Gentzsch Martina, Mall Marcus A. Ion channel modulators in cystic fibrosis. Chest. 2018;154:383\u201393.","journal-title":"Chest"},{"issue":"12","key":"2139_CR6","first-page":"1157","volume":"68","author":"M Cohen-Cymberknoh","year":"2013","unstructured":"Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A. Airway inflammation in Cystic Fibrosis: molecular mechanisms and clinical implication. British Thoracic Society. 2013;68(12):1157\u201362.","journal-title":"British Thoracic Society"},{"key":"2139_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","volume":"14","author":"AM Cantin","year":"2015","unstructured":"Cantin AM, Hartl D, Konstan MW, Chmiel JF. Inflammation in Cystic Fibrosis lung disease: pathogenesis and therapy. J Cyst Fibros. 2015;14:419\u201330.","journal-title":"J Cyst Fibros"},{"key":"2139_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lpm.2017.03.021","volume":"46","author":"R Somayaji","year":"2017","unstructured":"Somayaji R, Ramos KJ, Kapnadak SG, Aitken ML, Goss CH. Common clinical features of CF (respiratory disease and exocrine pancreatic insufficiency).  Presse Med. 2017;46:109\u201324.","journal-title":"Presse Med"},{"key":"2139_CR9","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.lpm.2017.05.011","volume":"46","author":"NJ Ronan","year":"2017","unstructured":"Ronan NJ, Elborn JS, Plant BJ. Current and emerging comorbidities in cystic fibrosis. La Presse Medicale. 2017;46:e125\u201338.","journal-title":"La Presse Medicale"},{"key":"2139_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.08.2010.3296","author":"I Shafiq","year":"2011","unstructured":"Shafiq I, Carroll MP, Nightingale JA, Daniels TV. Cepacia syndrome in a cystic fibrosis patient colonised with Burkholderia multivorans. BMJ Case Rep. 2011. https:\/\/doi.org\/10.1136\/bcr.08.2010.3296.","journal-title":"BMJ Case Rep"},{"key":"2139_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/BF01957574","volume":"151","author":"S Lanng","year":"1992","unstructured":"Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with Cystic Fibrosis. Eur J Pediatr. 1992;151:684\u20137.","journal-title":"Eur J Pediatr"},{"key":"2139_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jpeds.2016.09.068","volume":"182","author":"PR Sosnay","year":"2017","unstructured":"Sosnay PR, White TB, Farrell PM, Ren CL, Derichs N, Howenstine MS, Nick JA, De Boeck K. Diagnosis of cystic fibrosis in nonscreened populations. J Pediatrics. 2017;182:52\u20139.","journal-title":"J Pediatrics"},{"key":"2139_CR13","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","volume":"290","author":"Lisa Saiman","year":"2003","unstructured":"Saiman Lisa, Marshall Bruce C, Mayer-Hablett Nicole. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa. JAMA. 2003;290:1749\u201356.","journal-title":"JAMA"},{"key":"2139_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJM199901073400104","volume":"340","author":"BW Ramsey","year":"1999","unstructured":"Ramsey BW, Pepe MS, Quan JM, Otto KL, Montgomery AB, Williams-Warren J, Vasiljev-K M, Borowitz D, Bowman CM, Marshall BC, Marshall S. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med. 1999;340:23\u201330.","journal-title":"N Engl J Med"},{"key":"2139_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jcf.2012.10.004","volume":"11","author":"G D\u00f6ring","year":"2012","unstructured":"D\u00f6ring G, Flume P, Heijerman H, Elborn JS. Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros. 2012;11:461\u201379.","journal-title":"J Cyst Fibros"},{"issue":"63","key":"2139_CR16","first-page":"713","volume":"2014","author":"LA Inker","year":"2012","unstructured":"Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Tamura MK, Feldman HI. KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2012;2014(63):713\u201335.","journal-title":"Am J Kidney Dis"},{"key":"2139_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jcf.2013.03.005","volume":"12","author":"D Nazareth","year":"2013","unstructured":"Nazareth D, Walshaw M. A review of renal disease in cystic fibrosis. J Cyst Fibros. 2013;12:309\u201317.","journal-title":"J Cyst Fibros"},{"key":"2139_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1542-4758.2012.00675.x","volume":"16","author":"MC Florescu","year":"2012","unstructured":"Florescu MC, Lyden E, Murphy PJ, Florescu DF, Fillaus J. Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis. Hemod Int. 2012;16:414\u20139.","journal-title":"Hemod Int"},{"key":"2139_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1053\/j.jrn.2017.05.006","volume":"27","author":"Domenico Santoro","year":"2017","unstructured":"Santoro Domenico, Postorino Adele, Lucanto Cristina, Costa Stefano, Cristadoro Simona, Pellegrino Salvatore. Cystic fibrosis: a risk condition for renal disease. J Renal Nutr. 2017;27:470\u20133.","journal-title":"J Renal Nutr"},{"issue":"1","key":"2139_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40292-017-0236-x","volume":"25","author":"C Antza","year":"2018","unstructured":"Antza C, Doundoulakis I, Stabouli S, Kotsis V. Comparison among recommendations for the management of arterial hypertension issued by last US, Canadian, British and European Guidelines. High Blood Press Cardiovasc Prev. 2018;25(1):9\u201316.","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"2139_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. ATS\/ERS Task Force: standardisation of spirometry. EurRespir J. 2005;26:319\u201338.","journal-title":"EurRespir J"},{"key":"2139_CR22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. EurRespir J. 2005;26:948\u201368.","journal-title":"EurRespir J"},{"issue":"10","key":"2139_CR23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3345\/kjp.2013.56.10.456","volume":"56","author":"S Kelekci","year":"2013","unstructured":"Kelekci S, Karabel M, Ece A, \u015een V, G\u00fcne\u015f A, Yolba\u015f \u0130, \u015eahin C. Cystic fibrosis of pancreas and nephrotic syndrome: a rare association. Korean J Pediatr. 2013;56(10):456\u20138.","journal-title":"Korean J Pediatr."},{"key":"2139_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.clinbiochem.2017.01.008","volume":"50","author":"DA Degen","year":"2017","unstructured":"Degen DA, Janardan J, Barraclough KA, Scheneider HG, Barber T, Barton H. Predictive performance of different kidney function estimation equations in lung transplant patients. Clin Biochem. 2017;50:385\u201393.","journal-title":"Clin Biochem"},{"key":"2139_CR25","first-page":"78","volume":"33","author":"S Bianchi","year":"2016","unstructured":"Bianchi S, Baronti A, Caminotto R, Bigazzi R. Le alterazioni del metabolismo lipidico nella malattia renale cronica. Giornale italiano di nefrologia. 2016;33:78\u201385.","journal-title":"Giornale italiano di nefrologia"},{"key":"2139_CR26","unstructured":"Viazzi F, Bonino B, Ratto E, Desideri G, Pontremoli R. Iperuricemia e rischio renale. Giornale italiano di nefrologia 2015; 32."},{"key":"2139_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2018.10.007","volume":"278","author":"T Maruhashia","year":"2018","unstructured":"Maruhashia T, Hisatomeb I, Kiharaa Y, Higashi Y. Hyperuricemia and endotelial function: from molecular background to clinical perspectives. Atherosclerosis. 2018;278:226\u201331.","journal-title":"Atherosclerosis"},{"issue":"7","key":"2139_CR28","first-page":"1010","volume":"18","author":"S Lai","year":"2014","unstructured":"Lai S, Mariotti A, Coppola B, Lai C, Aceto P, Dimko M, Galani A, Innico G, Frassetti N, Mangiulli M, Cianci R. Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease\u2014preliminary data. Eur Rev Med Pharmacol Sci. 2014;18(7):1010\u20137.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"7","key":"2139_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/17476348.2016.1190646","volume":"10","author":"B Prentice","year":"2016","unstructured":"Prentice B, Hameed S, Verge CF, Ooi CY, Jaffe A, Widger J. Diagnosing cystic fibrosis-related diabetes: current methods and challenges. Expert Rev Respir Med. 2016;10(7):799\u2013811.","journal-title":"Expert Rev Respir Med."},{"issue":"5","key":"2139_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jcjd.2016.08.221","volume":"40","author":"V Boudreau","year":"2016","unstructured":"Boudreau V, Reynaud Q, Dubois CL, Coriati A, Desjardins K, Durieu I, Rabasa-Lhoret R. Screening for cystic fibrosis-related diabetes: matching pathophysiology and addressing current challenges. Can J Diabetes. 2016;40(5):466\u201370.","journal-title":"Can J Diabetes."},{"key":"2139_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. ATS\/ERS task force: standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J"},{"key":"2139_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948\u201368.","journal-title":"Eur Respir J"},{"issue":"3","key":"2139_CR33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jcf.2017.01.002","volume":"16","author":"R Szczesniak","year":"2017","unstructured":"Szczesniak R, Heltshe SL, Stanojevic S, Mayer-Hamblett N. Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: a statistical perspective for the clinical researcher. J Cyst Fibros. 2017;16(3):318\u201326.","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02139-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-02139-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02139-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:17:10Z","timestamp":1606177030000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-02139-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2139"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-02139-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"19 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Local Clinical Research Ethics Committee, Sapienza University of Rome. The study conforms to the principles outlined in the Declaration of Helsinki and we obtained a written consent by each patient enrolled.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest. All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. The manuscript is not under consideration for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"388"}}